Concepedia

Linda Eissenberg

LE

Statistics

Publications

18

Citations

1.9K

H-Index

17

Active since

1981

Affiliations

Washington University in St. Louis(Current)

The University of Texas MD Anderson Cancer Center

Mallinckrodt (United States)

MacroGenics (United States)

Linda Eissenberg is an author at Washington University in St. Louis specializing in life sciences, microbiology, and innate immunity.

ORCID

Publications per year

1981–2019

18

Publications

18

<i>Histoplasma capsulatum</i> α-(1,3)-glucan blocks innate immune recognition by the β-glucan receptor

Chad A. Rappleye, Linda Eissenberg, William E. Goldman · Proceedings of the National Academy of Sciences · 2007 · 418 citations · Full text

, , +17

An “off-the-shelf” fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

Matthew Cooper, Jaebok Choi, Karl Staser et al. · Leukemia · 2018 · 394 citations · Full text

, , +14

Histoplasma capsulatum modulates the acidification of phagolysosomes.

Linda Eissenberg, William E. Goldman, Paul H. Schlesinger · The Journal of Experimental Medicine · 1993 · 201 citations · Full text

, , +14

Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform

Muneera Al-Hussaini, Michael P. Rettig, Julie Ritchey et al. · Blood · 2015 · 174 citations · Full text

, , +14

Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia

Vanessa Buatois, Zoë Johnson, Susana Salgado-Pires et al. · Molecular Cancer Therapeutics · 2018 · 114 citations · Full text

, , +17

1–5 of 18